Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | MANGALAM Mangalam Drugs And Organics Limited Pharma · Small | VINEETLAB Vineet Laboratories Limited Pharma · Small | MAXHEALTH Max Healthcare Institute Limited Pharma · Large | LOTUSEYE Lotus Eye Hospital and Institute Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 2 | 2 | 35 | 13 |
| Verdict | OVERVALUED | OVERVALUED | WATCHLIST | OVERVALUED |
| Style | Distress Watch | Distress Watch | WATCHLIST | OVERVALUED |
| Piotroski | 3/9 | 2/9 | 8/9 | 6/9 |
| Valuation | 5/30 | 3/30 | 0/30 | 1/30 |
| Growth | 1/25 | 0/25 | 19/25 | 4/25 |
| Quality | 0/20 | 0/20 | 2/20 | 0/20 |
| Balance Sheet | 1/15 | 0/15 | 5/15 | 4/15 |
| Cash Flow | 1/10 | 7/10 | 4/10 | 4/10 |
| Price | ₹28.33 | ₹33.71 | ₹1,003 | ₹122.39 |
| P/E | — | — | 67.50 | 3065.00 |
| P/B | 0.44 | 4.70 | 9.83 | 4.08 |
| ROE | -35.20% | -89.50% | 12.70% | 0.13% |
| ROCE | -14.30% | -28.00% | 14.90% | 1.16% |
| Debt / Equity | 1.02 | 3.07 | 0.33 | 0.26 |
| FCF Yield | — | 11.98% | — | — |
| Dividend Y | — | — | 0.15% | — |
| Altman Z | 1.21 | 1.08 | 0.00 | 7.71 |
| Promoter % | 35.65% | 5.98% | 23.71% | 40.14% |
| Mkt Cap (₹Cr) | 45.00 | 66.80 | — | 245.00 |
| Graham # | — | — | ₹84.62 | ₹5.1 |
| Fair PE | 1.9 | 4.2 | 42.0 | 1.0 |
| MoS % | — | — | -672.9% | -308965.7% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startMANGALAM26
VINEETLAB58
MAXHEALTH93
LOTUSEYE183